This test is most useful if any of these apply to you.
Most people have never heard of this parasite, and most American labs will never spot it. But when it does show up in someone's gut, it can range from completely silent to life-threatening. Knowing whether you carry it matters because catching it early, before it ulcerates the colon, is the difference between a short course of antibiotics and surgery.
This test looks at a stool sample under the microscope for the organism itself. A result is either positive (the parasite was seen) or negative (it was not). There is no gray zone, and no reference range in the usual sense. If it is there, you treat it. If it is not, you move on.
B. coli (Balantidium coli, more recently reclassified as Balantioides coli) is a protozoan, meaning a single-celled organism that lives as a parasite in the large intestine. It is the largest protozoan known to infect humans, and it moves using tiny hair-like structures covering its surface (called cilia). It lives in two forms: a dormant, tough-shelled form (the cyst) that survives outside the body and spreads the infection, and an active form (the trophozoite) that multiplies in the colon and can invade the intestinal wall.
Pigs are the natural home for this parasite. Most human infections trace back to contact with pigs, pig manure, or food and water contaminated by pig feces. Raw vegetables and fresh produce can carry the cysts if they were irrigated or fertilized with contaminated material. Because the cysts are hardy, basic sanitation and clean water are the main things that keep it out of human populations.
Across the published research, roughly 4% of people worldwide carry this parasite, though the real burden is concentrated in tropical and subtropical regions with poor sanitation and free-range pig farming. Reports come mostly from India, Brazil, Venezuela, Ethiopia, and other parts of Asia, South America, and Africa. In the United States and Europe, it is rare enough that most doctors will never see a case.
Risk jumps sharply with pig exposure. In one study in Ga West Municipality, Ghana, 21.7% of pig farmers tested positive compared with 5.8% of their exposed household members. A separate study of pig farmers in Brazil found 14.9% carried the parasite on confirmatory testing. Lack of protective clothing, handling pig manure, drinking contaminated water, and eating unwashed produce all raise the odds.
| Who Was Studied | What Was Compared | What They Found |
|---|---|---|
| Pig farmers and their households in Ghana | Farmers vs. exposed household members | About 4 times as many farmers were infected (21.7% vs. 5.8%) |
| Adult pig farmers in Brazil | Occupationally exposed adults | About 15 in 100 tested positive by molecular testing |
| Global review across multiple regions | General population prevalence | Roughly 4 in 100 carried the parasite, mostly in tropical regions |
Sources: Aninagyei et al. (Ghana study), Class et al. (Brazilian pig farmer study), Silva et al. systematic review.
What this means for you: if you work with pigs, handle livestock feces, travel frequently to endemic regions, or regularly eat raw produce from rural tropical areas, your baseline odds of carrying this parasite are meaningfully higher than the general population's. That raised baseline is the main reason to consider this test if you have persistent, unexplained gut symptoms.
Many infections are silent. People carry the parasite without symptoms and only learn they have it through stool testing. When the parasite does cause illness, the classic picture is a dysentery-like syndrome: bloody, mucus-filled diarrhea, cramping abdominal pain, and sometimes fever. The organism invades the wall of the colon, which is what produces the bleeding.
In severe cases, the infection can progress to necrotizing inflammation of the colon, abdominal infection outside the gut (peritonitis), or toxic megacolon, a surgical emergency in which the colon dilates and becomes nonfunctional. Documented cases have required colectomy. Rare reports also describe the parasite in the lungs of a leukemia patient and in cervical and vaginal samples, suggesting it can occasionally spread outside the gut, though this is uncommon.
People with weakened immune systems are overrepresented in the severe and unusual cases. Documented reports include chronic diarrhea in a person with HIV, dysentery in a patient with non-Hodgkin lymphoma, and lung infection in a leukemia patient treated with chemotherapy. The pattern is consistent: the same parasite that produces mild or no symptoms in a healthy host can become invasive and dangerous when immune defenses are compromised by HIV, blood cancers, chemotherapy, transplant medications, or chronic illness.
If you are immunocompromised and develop persistent diarrhea, standard stool panels often miss this parasite because it is not on most multiplex molecular panels. Specifically asking for microscopy that includes B. coli, or ordering a test that names it, changes what you find.
This is a presence-or-absence test. The lab looks for the parasite's cysts or active forms in your stool sample under a microscope. There are no quartiles, tertiles, or numeric cutoffs because the organism either is there or is not.
| Result | What It Means | What Comes Next |
|---|---|---|
| Not detected | No parasite was seen in this stool sample | If symptoms persist, consider retesting on a separate day, since parasite shedding can be intermittent |
| Detected | The parasite was identified in your stool, confirming infection | Treatment is warranted, whether or not you have symptoms, because of the risk of progression and transmission |
A single negative result is less reassuring than it sounds if you have ongoing symptoms and meaningful exposure. Published diagnostic studies show that microscopy can miss intestinal parasites when shedding is low on the day of collection. Submitting stool on multiple separate days, or using a concentration technique at the lab, improves the odds of catching the organism when it is present.
A few specific situations can distort a single reading:
If you test positive and complete treatment, the key question is whether the parasite is truly gone. Published treatment regimens using tetracyclines and nitroimidazoles such as metronidazole typically produce rapid clinical improvement, but symptom resolution does not guarantee clearance. Repeating the stool test a few weeks after finishing treatment, and then again one to three months later, documents that the organism is no longer being shed. If you are immunocompromised or had severe disease, more frequent follow-up testing is reasonable.
If you test negative but symptoms persist, one additional stool examination on a different day is worth doing before concluding this parasite is not the cause. A single sample can miss low-level infection.
A positive result should prompt action, not watching. The standard approach, supported by case series and clinical experience summarized in the balantidiasis systematic review, is a course of antibiotics active against this organism. Tetracycline and nitroimidazoles such as metronidazole or secnidazole are the mainstays, often used together or sequentially. Early treatment prevents the progression to invasive colitis, bleeding, and surgical complications.
Treatment decisions are best made with a clinician familiar with parasitic infections, such as an infectious disease specialist or a gastroenterologist with tropical medicine experience. Alongside treatment, consider ordering companion stool tests to check for other parasites that travel the same transmission routes, including Giardia, Cryptosporidium, and Entamoeba histolytica. Household members with shared exposures (especially children, farm workers, or anyone with diarrhea) should also be tested. If you work with pigs or handle livestock feces, reviewing your protective equipment and hygiene practices with an occupational health provider reduces the chance of reinfection.
If your test is positive and you have severe symptoms, blood in the stool, high fever, or abdominal pain that worsens over hours to a day, seek medical care promptly. Cases that progress to toxic megacolon or peritonitis can require surgery, and earlier intervention produces better outcomes.
Evidence-backed interventions that affect your Balantidium Coli level
Balantidium Coli is best interpreted alongside these tests.